These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 24970925)
1. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7. Kaiser M; Sobottka H; Fischer W; Schaefer M; Nörenberg W J Pharmacol Exp Ther; 2014 Sep; 350(3):531-42. PubMed ID: 24970925 [TBL] [Abstract][Full Text] [Related]
2. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor. Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492 [TBL] [Abstract][Full Text] [Related]
3. Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors. Nörenberg W; Sobottka H; Hempel C; Plötz T; Fischer W; Schmalzing G; Schaefer M Br J Pharmacol; 2012 Sep; 167(1):48-66. PubMed ID: 22506590 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels. Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706 [TBL] [Abstract][Full Text] [Related]
5. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating. Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel purine-based heterocyclic P2X7 receptor antagonists. Kwak SH; Lee WG; Lee YJ; Lee SD; Kim YC; Ko H Bioorg Chem; 2015 Aug; 61():58-65. PubMed ID: 26123174 [TBL] [Abstract][Full Text] [Related]
11. P2X4 receptor regulates P2X7 receptor-dependent IL-1β and IL-18 release in mouse bone marrow-derived dendritic cells. Sakaki H; Fujiwaki T; Tsukimoto M; Kawano A; Harada H; Kojima S Biochem Biophys Res Commun; 2013 Mar; 432(3):406-11. PubMed ID: 23428419 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists. Park JH; Lee GE; Lee SD; Ko H; Kim YC Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056 [TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release. Barberà-Cremades M; Baroja-Mazo A; Gomez AI; Machado F; Di Virgilio F; Pelegrín P FASEB J; 2012 Jul; 26(7):2951-62. PubMed ID: 22490780 [TBL] [Abstract][Full Text] [Related]
14. ATP-induced currents carried through P2X7 receptor in rat myometrial cells. Miyoshi H; Yamaoka K; Urabe S; Kudo Y Reprod Sci; 2012 Dec; 19(12):1285-91. PubMed ID: 22814097 [TBL] [Abstract][Full Text] [Related]
15. Effects of dexamethasone on purinergic signaling in murine mast cells: Selective suppression of P2X7 receptor expression. Yoshida K; Ito M; Hoshino Y; Matsuoka I Biochem Biophys Res Commun; 2017 Dec; 493(4):1587-1593. PubMed ID: 28988113 [TBL] [Abstract][Full Text] [Related]
16. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation. Calzaferri F; Narros-Fernández P; de Pascual R; de Diego AMG; Nicke A; Egea J; García AG; de Los Ríos C J Med Chem; 2021 Feb; 64(4):2272-2290. PubMed ID: 33560845 [TBL] [Abstract][Full Text] [Related]
18. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones. de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623 [TBL] [Abstract][Full Text] [Related]
19. Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations. Nörenberg W; Hempel C; Urban N; Sobottka H; Illes P; Schaefer M J Biol Chem; 2011 Apr; 286(13):11067-81. PubMed ID: 21262970 [TBL] [Abstract][Full Text] [Related]
20. Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation. Danquah W; Meyer-Schwesinger C; Rissiek B; Pinto C; Serracant-Prat A; Amadi M; Iacenda D; Knop JH; Hammel A; Bergmann P; Schwarz N; Assunção J; Rotthier W; Haag F; Tolosa E; Bannas P; Boué-Grabot E; Magnus T; Laeremans T; Stortelers C; Koch-Nolte F Sci Transl Med; 2016 Nov; 8(366):366ra162. PubMed ID: 27881823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]